These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7857315)
1. Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity. Balwierczak JL; Kukkola PJ; Savage P; Jeng AY Biochem Pharmacol; 1995 Jan; 49(3):291-6. PubMed ID: 7857315 [TBL] [Abstract][Full Text] [Related]
2. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1. Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704 [TBL] [Abstract][Full Text] [Related]
3. Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme. Pollock DM; Shiosaki K; Sullivan GM; Opgenorth TJ Biochem Biophys Res Commun; 1992 Jul; 186(2):1146-50. PubMed ID: 1497648 [TBL] [Abstract][Full Text] [Related]
4. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi. Yap EY; Battistini B; McKay KO Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217 [TBL] [Abstract][Full Text] [Related]
5. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme. Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470 [TBL] [Abstract][Full Text] [Related]
6. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. McMahon EG; Palomo MA; Moore WM J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358 [TBL] [Abstract][Full Text] [Related]
7. Endothelin-converting enzyme and its in vitro and in vivo inhibition. Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349 [TBL] [Abstract][Full Text] [Related]
8. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane. Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480 [TBL] [Abstract][Full Text] [Related]
9. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon. Keller PM; Lee CP; Fenwick AE; Atkinson ST; Elliott JD; DeWolf WE Biochem Biophys Res Commun; 1996 Jun; 223(2):372-8. PubMed ID: 8670289 [TBL] [Abstract][Full Text] [Related]
10. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461 [TBL] [Abstract][Full Text] [Related]
11. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11. Held HD; Raschak M; Uhlig S Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301 [TBL] [Abstract][Full Text] [Related]
12. Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3. Tsukahara Y; Matsumura Y; Kuninobu K; Kojima T; Takaoka M; Morimoto S Life Sci; 1993; 53(6):465-71. PubMed ID: 8341132 [TBL] [Abstract][Full Text] [Related]
13. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition. Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872 [TBL] [Abstract][Full Text] [Related]
14. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery. Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178 [TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats. Hassan M; Kashimura H; Matsumaru K; Nakahara A; Fukutomi H; Muto H; Goto K; Tanaka N Life Sci; 1997; 61(10):PL 141-7. PubMed ID: 9296343 [TBL] [Abstract][Full Text] [Related]
16. Characterization of endothelin converting enzyme from intact cells of a permanent human endothelial cell line, EA.hy926. Ahn K; Pan SM; Zientek MA; Guy PM; Sisneros AM Biochem Mol Biol Int; 1996 Jun; 39(3):573-80. PubMed ID: 8828809 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1. Firooznia F; Gude C; Chan K; Tan J; Fink CA; Savage P; Beil ME; Bruseo CW; Trapani AJ; Jeng AY Bioorg Med Chem Lett; 2002 Nov; 12(21):3059-62. PubMed ID: 12372501 [TBL] [Abstract][Full Text] [Related]
18. Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors. Vatter H; Schilling L; Schmiedek P; Ehrenreich H J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S64-7. PubMed ID: 9595402 [TBL] [Abstract][Full Text] [Related]
20. The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells. Ahn K; Beningo K; Olds G; Hupe D Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8606-10. PubMed ID: 1528868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]